Reports submitted in 2026-Q2 · page 29
Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 99.00 % area, n=1126. Read the 2026-Q2 state-of-the-index report →
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-042352 | ARA-290 | Homopeptide | HOMO-2601-T3123 | PeptideMeter | 2026-Q2 | 99.61 | 4.23 | 94.8 | Buyer-sourced | 0 | PASS |
| AX-2026-042038 | Epitalon | HYB | HYB-2603-U7133 | VendorInvestigate | 2026-Q2 | 99.86 | 6.83 | 95.7 | Buyer-sourced | 0 | FAIL |
| AX-2026-041663 | PT-141 (Bremelanotide) | FGP | FGP-2602-Y8741 | Janoshik | 2026-Q2 | 99.33 | 4.04 | 91.4 | Buyer-sourced | 0 | PASS |
| AX-2026-041655 | Tirzepatide | FGP | FGP-2605-R8870 | Kestrel | 2026-Q2 | 98.20 | 6.52 | 96.5 | Buyer-sourced | 0 | PASS |
| AX-2026-042593 | Tirzepatide | HJ | HJ-2511-B6617 | Janoshik | 2026-Q2 | 98.87 | 5.67 | 106.3 | Buyer-sourced | 0 | PASS |
| AX-2026-041365 | Tirzepatide | WWB | WWB-2604-T3876 | Janoshik | 2026-Q2 | 99.25 | 5.00 | — | Buyer-sourced | 0 | PASS |